You are here: Home >>About Us >>Expert advisers
Expert advisers
Mark Winnett, Global Strategy Advisor

Mr. Winnett, a 30 year veteran of the R&D, biotech, and pharmaceutical industry, is a proven leader of cross functional teams that collaborate, innovate, and adapt quickly. He has worked on dozens of drug development projects in 6 countries, with a focus on immunology and oncology. His final assignment was to lead the development of CNTO 6785 at Janssen R&D.
The common theme throughout Mark’s career has been to bring diverse experts together into a high performing, cross functional development team despite disciplinary, geographic, organizational or cultural barriers. His special passion is for the early stages, when the team (and perhaps the sponsor too) have not yet defined a R&D strategy to match the corporate vision and goals.
Mark brings his experience and know-how, coaching the project and management teams on global team leadership, product development and management, and international collaboration.

Timothy P. Coogan PhD, DABT
Tim has almost 30 years of experience in Nonclinical Drug Safety, with expertise focusing on building nonclinical safety assessment strategies for biologic and small molecule therapeutics in order to guide safe first in human use and continued clinical development through registration. 
Tim worked for 26 years at Johnson & Johnson (J&J) within their pharmaceutical sector holding various positions with increasing responsibility. Prior to leaving J&J, he was Vice President and Global Head of Nonclinical Drug Safety for Janssen R&D. He has had responsibility for the development of many biologic and small molecule therapeutics, a number of which ultimately achieved global registration and approval. Additionally, as an expert in the area of nonclinical support for therapeutics to be used in pediatric populations. he has given numerous presentations, and written several articles and book chapters on this topic.
Tim earned a Ph.D. in Pharmacology from the University of the Sciences (formerly The Philadelphia College of Pharmacy & Science) and is Board Certified in Toxicology. He is a full member of the Society of Toxicology, a Past-President of the Mid-Atlantic Chapter of the Society of Toxicology and was an Adjunct Assistant Professor in the School of Pharmacy at Temple University.